A proposed genetically modified mustard crop is sharpening divisions within Canada’s agriculture sector as producers weigh potential productivity gains against the risk of losing key export markets.

The crop, a hybrid developed to produce canola-like oil while tolerating drought and herbicides, is being positioned as a tool to expand production in arid regions where traditional oilseeds often struggle. Supporters say the technology could improve farm margins and stabilize yields in areas facing increasing climate stress.

Opposition is centred in the country’s export-focused mustard industry, where growers depend on strict non-GMO standards in overseas markets. Canada exports roughly $150 million worth of mustard annually, with a significant share destined for Europe, where buyers maintain tight restrictions on genetically modified crops.

Industry groups warn that even low levels of contamination could trigger trade disruptions. The new crop and conventional mustard belong to the same species, allowing cross-pollination through wind or insects, raising the likelihood of unintended mixing in the supply chain.

The concern is reinforced by past experience. In 2009, traces of a genetically modified flax variety were detected in exports to Europe, leading to a sharp decline in shipments and long-term market damage. Growers say the episode remains a cautionary example of how quickly export confidence can collapse when GMO contamination is detected.

Proponents of the new mustard argue that modern safeguards and production controls can limit the risk of cross-contamination. They also point to the broader role of biotechnology in maintaining competitiveness, particularly as climate pressures alter growing conditions across the Prairies.

The dispute reflects a wider policy tension in Canadian agriculture, where innovation is often encouraged through a regulatory system that evaluates products based on their characteristics rather than the method used to develop them. At the same time, global acceptance of genetically modified crops remains uneven, with European markets in particular maintaining stricter standards that influence export viability.

As regulatory decisions approach, the sector faces a fundamental question of whether higher yields and expanded production can coexist with an export model built on non-GMO assurances, or whether the introduction of the crop will force a shift in market strategy.